A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Clinical trial NCT07281976 · RECRUITING
Trial details
- NCT number
- NCT07281976
- Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-27
- Primary completion
- 2027-12-31
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.